Document is current

Any future updates will be listed below

A real-world study of tyrosine kinase inhibitors plus anti-PD-1 immunotherapy with or without chemoembolization for hepatocellular carcinoma patients with main portal vein invasion

Crossref DOI link: https://doi.org/10.1007/s00261-024-04490-7

Published Online: 2024-07-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark